CliffBio
small molecule

METRONIDAZOLE IN PLASTIC CONTAINER

METRONIDAZOLE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETRONIDAZOLE IN PLASTIC CONTAINER
Active ingredientMETRONIDAZOLE
Strength500MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMarch 2008
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.